Human ovarian cancer stem cells

被引:82
|
作者
Bapat, Sharmila A. [1 ]
机构
[1] Natl Ctr Cell Sci, Pune 411007, Maharashtra, India
关键词
GENE-EXPRESSION PROFILE; ACUTE MYELOID-LEUKEMIA; DRUG-RESISTANCE; SIDE POPULATION; PROSPECTIVE IDENTIFICATION; MULTIDRUG-RESISTANCE; SURFACE EPITHELIUM; CD133; CARCINOMA; MARKERS;
D O I
10.1530/REP-09-0389
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The isolation and identification of stem-like cells in solid tumors or cancer stem cells (CSCs) have been exciting developments of the last decade, although these rare populations had been earlier identified in leukemia. CSC biology necessitates a detailed delineation of normal stem cell functioning and maintenance of homeostasis within the organ. Ovarian CSC biology has unfortunately not benefited from a pre-established knowledge of stem cell lineage demarcation and functioning in the normal organ. In the absence of such information, some of the classical parameters such as long-term culture-initiating assays to isolate stem cell clones from tumors, screening and evaluation of other epithelial stem cell surface markers, dye efflux, and label retention have been applied toward the putative isolation of CSCs from ovarian tumors. The present review presents an outline of the various approaches developed so far and the various perspectives revealed that are now required to be dealt with toward better disease management. Reproduction (2010) 140 33-41
引用
收藏
页码:33 / 41
页数:9
相关论文
共 50 条
  • [41] Cancer stem-like cells can be isolated with drug selection in human ovarian cancer cell line SKOV3
    Ma, Li
    Lai, Dongmei
    Liu, Te
    Cheng, Weiwei
    Guo, Lihe
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2010, 42 (09) : 593 - 602
  • [42] Cancer stem cells: emerging actors in both basic and clinical cancer research
    Karakas, Didem
    Cevatemre, Buse
    Ulukaya, Engin
    TURKISH JOURNAL OF BIOLOGY, 2014, 38 (06) : 829 - 838
  • [43] Stem cells, melanoma and cancer stem cells: the good, the bad and the evil?
    Menaa, F.
    Houben, R.
    Eyrich, M.
    Broecker, E. B.
    Becker, J. C.
    Wischhusen, J.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2009, 144 (03): : 287 - 296
  • [44] Cancer stem cells and personalized cancer nanomedicine
    Gener, Petra
    de Sousa Rafael, Diana Fernandes
    Fernandez, Yolanda
    Sayos Ortega, Joan
    Arango, Diego
    Abasolo, Ibane
    Videira, Mafalda
    Schwartz, Simo, Jr.
    NANOMEDICINE, 2016, 11 (03) : 307 - 320
  • [45] The Implications of Cancer Stem Cells for Cancer Therapy
    Jiang, Wenjing
    Peng, Jianhua
    Zhang, Yue
    Cho, William C. S.
    Jin, Kunlin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (12) : 16636 - 16657
  • [46] Epithelial-mesenchymal transition triggers cancer stem cell generation in human thyroid cancer cells
    Lan, Ling
    Luo, Yong
    Cui, Dai
    Shi, Bing-Yin
    Deng, Wei
    Huo, Li-Li
    Chen, Hai-Ling
    Zhang, Guo-Ying
    Deng, Li-Li
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 43 (01) : 113 - 120
  • [47] Ovarian cancer stem cells: ready for prime time?
    Sabini, Carlotta
    Sorbi, Flavia
    Cunnea, Paula
    Fotopoulou, Christina
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2020, 301 (04) : 895 - 899
  • [48] Ovarian cancer stem cells: Are they real and why are they important?
    Shah, Monjri M.
    Landen, Charles N.
    GYNECOLOGIC ONCOLOGY, 2014, 132 (02) : 483 - 489
  • [49] AS602801 Sensitizes Ovarian Cancer Stem Cells to Paclitaxel by Down-regulating MDR1
    Yamamoto, Masahiro
    Suzuki, Shuhei
    Togashi, Keita
    Sanomachi, Tomomi
    Seino, Shizuka
    Kitanaka, Chifumi
    Okada, Masashi
    ANTICANCER RESEARCH, 2019, 39 (02) : 609 - 617
  • [50] Isolation and characterization of stem-like cells from a human ovarian cancer cell line
    Lijuan Wang
    Roman Mezencev
    Nathan J. Bowen
    Lilya V. Matyunina
    John F. McDonald
    Molecular and Cellular Biochemistry, 2012, 363 : 257 - 268